Published in Cancer Weekly, January 6th, 2009
"The cytotoxicity has been attributed, in part, to the oxidative stress generated by the drug. Riboflavin is a micronutrient known for its photosensitization characteristics. Owing to the emergence of photodynamic therapy as a modality for the treatment of solid tumors and other accessible lesions in terms of opthalmic,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-01-06)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.